In May 2010, VASO "was appointed by GEHC as its exclusive representative for the sale of select GE diagnostic imaging equipment to specific market segments in the 48 contiguous states of the United States and the District of Columbia. The original agreement ("GEHC Agreement") was for three years ending June 30, 2013; it has been extended several times with the current extension through December 31, 2026, subject to earlier termination under certain conditions."
Given that their contract with GEHC has been extended "several times", I'm confident that their relationship is very solid and investable. VASO's other units are currently money-losers, which is why I said that if the company got rid of them the stock would be that much more valuable. As it is, I view the GEHC contract as quite undervalued by the stock market...
We make a living by what we get, we make a life by what we give.
--Winston Churchill
